Marketwatch Cadila Healthcare surges 10% on 4-fold jump in Q2 profit Admin November 3, 2020 “We remain positive on Cadila on account of robust launch momentum, build-up of a complex product pipeline including injectables and transdermals, and the completion of remediation at Moraiya,” said Motilal Oswal Securities. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
